Hyperfine (NASDAQ:HYPR) Stock Rating Upgraded by Zacks Research

Hyperfine (NASDAQ:HYPR) was upgraded by Zacks Research to a “hold” rating in a research report issued on Thursday,Zacks.com reports.

Several other brokerages have also commented on HYPR. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hyperfine in a research report on Thursday, January 22nd. Lake Street Capital upped their price target on shares of Hyperfine from $2.00 to $2.50 and gave the company a “buy” rating in a research note on Thursday. Two investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $1.45.

Hyperfine Price Performance

Shares of HYPR stock opened at $1.24 on Thursday. The stock’s fifty day moving average price is $1.15 and its 200 day moving average price is $1.20. Hyperfine has a 1-year low of $0.53 and a 1-year high of $2.22. The company has a market cap of $120.49 million, a price-to-earnings ratio of -2.82 and a beta of 1.09.

Hyperfine (NASDAQ:HYPR) last released its quarterly earnings results on Wednesday, March 18th. The company reported ($0.06) EPS for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.02. Hyperfine had a negative return on equity of 95.09% and a negative net margin of 262.29%.The company had revenue of $5.29 million during the quarter, compared to analysts’ expectations of $5.30 million. As a group, equities research analysts anticipate that Hyperfine will post -0.57 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in HYPR. EP Wealth Advisors LLC acquired a new stake in Hyperfine during the 4th quarter worth about $34,000. Sanctuary Advisors LLC lifted its holdings in shares of Hyperfine by 130.9% in the 4th quarter. Sanctuary Advisors LLC now owns 39,938 shares of the company’s stock valued at $39,000 after buying an additional 22,638 shares during the period. Kathmere Capital Management LLC purchased a new stake in shares of Hyperfine in the fourth quarter worth about $51,000. Millennium Management LLC purchased a new stake in shares of Hyperfine in the fourth quarter worth about $55,000. Finally, Cerity Partners LLC acquired a new stake in Hyperfine during the fourth quarter worth about $59,000. 15.03% of the stock is currently owned by institutional investors and hedge funds.

Hyperfine Company Profile

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.